Source link : https://newshealth.biz/health-news/gene-therapy-maintains-efficacy-in-hemophilia-b-out-to-5-years/
(MedPage Today) — ORLANDO — Patients with hemophilia B continued to experience low annualized bleeding rates and stable endogenous factor IX expression 5 years after a single infusion of etranacogene dezaparvovec (Hemgenix), the final analysis… Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118932 Author : Publish date : 2025-12-10 17:18:00 Copyright for syndicated content belongs to the linked Source.
The post Gene Therapy Maintains Efficacy in Hemophilia B Out to 5 Years first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-10 17:18:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8